featured
Autologous HSTC in Patients With "Aggressive" MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Autologous Haematopoietic Stem Cell Transplantation as a First-Line Disease-Modifying Therapy in Patients With 'Aggressive' Multiple Sclerosis
Mult. Scler. 2021 Feb 10;[EPub Ahead of Print], J Das, JA Snowden, J Burman, MS Freedman, H Atkins, M Bowman, RK Burt, R Saccardi, C Innocenti, S Mistry, PJ Laud, H Jessop, B SharrackFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.